Development of a Novel Quality Improvement Indicator Based on the Hemolysis Index
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hemolysis frequently causes preanalytical errors in laboratory measurements. We aimed to develop a quality improvement indicator for evaluating the extent of inappropriate procedures causing hemolysis in clinical samples collected in medical care units. We defined the threshold value of the hemolysis index (H index) causing significant interference with analyte measurement and analyzed the H index values of clinical samples in relation to the threshold. The H index threshold value causing a 10% bias in the measurement of lactate dehydrogenase was found to be 25. The monthly mean H index and monthly frequency of samples with an H index >25 were significantly different among the types of ward (P=0.001, respectively), and significantly decreased after replacement of a laboratory centrifuge lacking temperature control (20.6±0.58 vs 23.30±1.08, P=0.01; 23.4±1.69% vs 32.6±1.78%, P=0.01). The monthly mean H index and the monthly frequency of samples with an H index above a threshold value may be useful quality improvement indicators for detection of inappropriate procedures in the acquisition and handling of blood samples in medical care units.
Abstract
Hemolysis frequently causes preanalytical errors in laboratory measurements. We aimed to develop a quality improvement indicator for evaluating the extent of inappropriate procedures causing hemolysis in clinical samples collected in medical care units. We defined the threshold value of the hemolysis index (H index) causing significant interference with analyte measurement and analyzed the H index values of clinical samples in relation to the threshold. The H index threshold value causing a 10% bias in the measurement of lactate dehydrogenase was found to be 25. The monthly mean H index and monthly frequency of samples with an H index >25 were significantly different among the types of ward (P=0.001, respectively), and significantly decreased after replacement of a laboratory centrifuge lacking temperature control (20.6±0.58 vs 23.30±1.08, P=0.01; 23.4±1.69% vs 32.6±1.78%, P=0.01). The monthly mean H index and the monthly frequency of samples with an H index above a threshold value may be useful quality improvement indicators for detection of inappropriate procedures in the acquisition and handling of blood samples in medical care units.
참고문헌 (12)
- Blank DW, "Hemoglobin interference from in vivo hemolysis", Clin Chem, 31, pp.1566~1569 (1985)
- Van Lente F, "Evaluation of a nephelometric assay for haptoglobin and its clinical usefulness", Clin Chem, 25, pp.2007~2010 (1979)
- Witte DL, "Effects of bilirubin on detection of hydrogen peroxide by use of peroxidase", Clin Chem, 24, pp.1778~1782 (1978)
- Spain MA, "Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays, and the effect of ferrocyanide", Clin Chem, 32, pp.518~521 (1986)
- Kroll MH, "Evaluating interference caused by lipemia", Clin Chem, 50, pp.1968~1969 (2004)
- Bornhorst JA, "Assay-specific differences in lipemic interference in native and intralipid-supplemented samples", Clin Chem, 50, pp.2197~2201 (2004)
- Aw TC, "Pseudohyponatremia", Am J Emerg Med, 3, pp.236~239 (1985)
- Lippi G, "Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories", Clin Chem Lab Med, 46, pp.764~772 (2008)
- 신동훈, "Development of an Integrated Reporting System for Verifying Hemolysis, Icterus, and Lipemia in Clinical Chemistry Results", Annals of Laboratory Medicine, 34(4), pp.307~312 (2014), 대한진단검사의학회
- Clinical Laboratory and Standards Institute, "Hemolysis, icterus, and lipemia", turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline, C56-A, 2012
- "Serum indices: Reduction of clinical errors in laboratory medicine"[URL]
- Shahangian S, "Laboratory medicine quality indicators: a review of the literature", Am J Clin Pathol, 131, pp.418~431 (2009)